Nikolaeva-Koleva, Magdalena
Butron, Laura
González-Rodríguez, Sara
Devesa, Isabel
Valente, Pierluigi
Serafini, Marta
Genazzani, Armando A.
Pirali, Tracey
Ballester, Gregorio Fernández
Fernández-Carvajal, Asia
Ferrer-Montiel, Antonio
Funding for this research was provided by:
Ministerio de Ciencia, Innovación y Universidades (DI-16-08303, PTA2017-14381-I, RTC-2017-6507-1, RTI2018-097189-B-C21)
Universidad Miguel Hernandez
Article History
Received: 10 January 2020
Accepted: 17 December 2020
First Online: 8 January 2021
Competing interests
: AFC, GFB and AFM are founders and shareholders of AntalGenics. ID is an employee of AntalGenics. AFM, AFC, TP and AAG are inventors of the patent protecting compound AG1529. AAG has waived his rights to benefit from the exploitation of the results towards pharmaceutical products. The other authors declare no conflict of interest.